| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
T2 Biosystems, Inc. (TTOO) has 0 insiders with recent SEC Form 4 filings, including 6 buys and 8 sells. TTOO is classified in the Life Sciences Tools & Services industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 1, 2021 | McDonough John | Director | Sell | 18,182 | $1.16 | $21,091.12 | -3.4% | |
| Jul 1, 2021 | Cumming John W | Director | Sell | 18,182 | $1.16 | $21,091.12 | -26.3% | |
| Mar 25, 2021 | Gibbs Michael Terrence | General Counsel | Sale+OE | 8,758 | $1.56 | $13,662.48 | -10.7% | |
| Mar 17, 2021 | Barclay Alec | Chief Operations Officer | Sell | 12,494 | $1.86 | $23,238.84 | -14.4% | |
| Mar 17, 2021 | Pare Anthony | Chief Commercial Officer | Sell | 9,620 | $1.84 | $17,700.80 | -23.3% | |
| Feb 23, 2021 | Gibbs Michael Terrence | General Counsel | Sale+OE | 7,280 | $2.06 | $14,996.80 | -10.0% | |
| Feb 23, 2021 | Sprague John M | Chief Financial Officer | Sale+OE | 5,250 | $2.04 | $10,710.00 | -12.9% | |
| Feb 23, 2021 | Barclay Alec | Chief Operations Officer | Sale+OE | 7,280 | $2.06 | $14,996.80 | -10.0% | |
| May 20, 2020 | Goldman Sachs & Co. LLC | 10% Owner | Buy | 17,954 | $0.78 | $14,083.37 | +0.1% | |
| May 20, 2020 | Jones Adrian M | Director | Buy | 17,954 | $0.78 | $14,083.37 | +0.1% |